Abstract:Objective: Type 2 diabetes (T2D) is one of the centenarian metabolic disorders and is considered as a stellar and leading health issue worldwide. According to the International Diabetes Federation (IDF) Diabetes Atlas and National Diabetes Statistics, the number of diabetic patients will increase at an exponential rate from 463 to 700 million by the year 2045. Thus, there is a great need for therapies targeting functions that can help in maintaining the homeostasis of glucose levels and improving insulin sensitivity. 5' adenosine monophosphate-activated protein kinase (AMPK) activation, by various direct and indirect factors, might help to overcome the hurdles (like insulin resistance) associated with the conventional approach. Materials and results: A thorough review and analysis was conducted using various database including MEDLINE and EMBASE databases, with Google scholar using various keywords. This extensive review concluded that various drugs (plant-based, synthetic indirect/direct activators) are available, showing tremendous potential in maintaining the homeostasis of glucose and lipid metabolism, without causing insulin resistance, and improving insulin sensitivity. Moreover, these drugs have an effect against diabetes and are therapeutically beneficial in the treatment of diabetes-associated complications (neuropathy and nephropathy) via mechanism involving inhibition of nuclear translocation of SMAD4 (SMAD family member) expression and association with peripheral nociceptive neurons mediated by AMPK. Conclusion: From the available information, it may be concluded that various indirect/direct activators show tremendous potential in maintaining the homeostasis of glucose and lipid metabolism, without resulting in insulin resistance, and may improve insulin sensitivity, as well. Therefore, in a nut shell, it may be concluded that the regulation of APMK functions by various direct/indirect activators may bring promising results. These activators may emerge as a novel therapy in diabetes and its associated complications.

The AMPK/cAMP Metabolic Signaling Axis as a Possible Therapeutic Target for Diabetes

AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome

A spotlight on underlying the mechanism of AMPK in diabetes complications

Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications

Dietary Bioactive Ingredients Modulating the cAMP Signaling in Diabetes Treatment

AMPK as a Therapeutic Target for Treating Metabolic Diseases

Natural activators of AMPK signaling: potential role in the management of type-2 diabetes

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Autophagy-nutrient sensing pathways in diabetic complications

Targeting of AMP-activated protein kinase: prospects for computer-aided drug design

AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention

AMPK signalling in health and disease

AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules

AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases

Emerging Role of cAMP/AMPK Signaling

The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets

Critical Role for AMPK in Metabolic Disease-Induced Chronic Kidney Disease

AMPK As A Target in Rare Diseases